BMJ 2000;320:1210 ( 29 April )

Letters

Use of unlabelled and off licence drugs in children

    Use of unlicensed drugs may be recommended in guidelines
    A European paediatric rule is needed to protect children

Use of unlicensed drugs may be recommended in guidelines

The first 150 words of the full text of this article appear below.

EDITOR---Conroy et al report the widespread use of drugs that are either not licensed for use in children or are prescribed outside the terms of their product licence (off label prescribing) in children admitted to hospital.1 Although it is not illegal to use medicines in this way, the responsibility for any adverse events becomes the clinician's or the pharmacist's rather than the manufacturer's. However, much unlicensed use may be recommended in local or national guidelines.

As part of our trust's response to the use of unlicensed drugs in children, I reviewed all drugs recommended in our local paediatric medical guidelines. These contained 69 guidelines for acute management and elective investigation of children. The guidelines recommended 86 drugs, but only 47 (55%) were licensed for use in children. A further 14 drugs were licensed only for children above a certain age or weight, 24 were unlicensed or off label, and the status of one . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Article

Survey of unlicensed and off label drug use in paediatric wards in European countries
Sharon Conroy, Imti Choonara, Piero Impicciatore, Angelika Mohn, Henrik Arnell, Anders Rane, Carmen Knoeppel, Hannsjoerg Seyberth, Chiara Pandolfini, Maria Pia Raffaelli, Francesca Rocchi, Maurizio Bonati, Geert `t Jong, Matthijs de Hoog, and John van den Anker
BMJ 2000 320: 79-82. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Ruperto, N, Garcia-Munitis, P, Villa, L, Pesce, M, Aggarwal, A, Fasth, A, Avcin, T, Bae, S-C, Balogh, Z, Li, C, De Inocencio, J, Dibra, M, Dolezalova, P, Miedany, Y E., Flato, B, Harjacek, M, Huppertz, H-I, Kanakoudi-Tsakalidou, F, Wulffraat, N, Lahdenne, P, Melo-Gomes, J A, Mihaylova, D, Nielsen, S, Nikishina, I, Ozdogan, H, Pagava, K, Panaviene, V, Prieur, A-M, Romicka, A-M, Rumba, I, Shafaie, N, Susic, G, Takei, S, Uziel, Y, Vesely, R, Woo, P, Martini, A, for the Paediatric Rheumatology International Tria, (2005). PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis 64: 1101-1106 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Clinical trials in children: waiting for an european decision
Adriana Ceci
bmj.com, 1 Sep 2000 [Full text]



Access jobs at BMJ Careers
Whats new online at Student 

BMJ